Explorer les evidences

0,3 %State-level HIV prevalence in Nigeria ranged from 0.3% to 4.3% based on data from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) conducted from July to December 2018.

NigeriaVIH/sidaobservé 2018publié 2022PloS onePubMeddocument de 5 observations

40 %The proportion of viral non-suppressed participants among youth living with HIV in Nigeria was 40% at baseline.

NigeriaVIH/sidaobservé 2021publié 2025AIDS and behaviorPubMeddocument de 2 observations

1,9 %Women aged 15 to 49 years in Nigeria have an HIV prevalence rate of 1.9%.

NigeriaVIH/sidapublié 2022The Pan African medical journalPubMeddocument de 2 observations

500 000 peopleBased on NAIIS results, funds were provided to place an additional 500,000 HIV-positive Nigerians on antiretroviral therapy by the end of 2020.

NigeriaVIH/sidaobservé 2020publié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 6 observations

0,5 %The prevalence of HIV in the study population was 0.5%.

NigeriaVIH/sidapublié 2025American journal of clinical pathologyPubMeddocument de 5 observations

6 %Only 6% of women had HIV tests during labour.

NigeriaVIH/sidaobservé 2013publié 2020Journal of biosocial sciencePubMeddocument de 4 observations

0,316 rhoThere was a significant correlation between knowledge and practice of HIV PEP among doctors (Spearman's rho = 0.316, p < 0.05).

NigeriaVIH/sidapublié 2020West African journal of medicinePubMeddocument de 6 observations

22,7 %Three months after the intervention, the proportion of respondents with low dietary diversity significantly decreased from 42.7% to 22.7% in the study group.

NigeriaVIH/sidaobservé three months after the interventionpublié 2023African health sciencesPubMeddocument de 3 observations

90 %Viral load testing coverage among children and adolescents living with HIV remained high at 90% between baseline (October-December 2019) and endline (January-March 2021).

NigeriaVIH/sidaobservé January-March 2021publié 2023PloS onePubMeddocument de 8 observations

2,3 aORThose who had disclosed their HIV status were twice as likely to adhere to HIV medication, with an adjusted odds ratio of 2.3.

NigeriaVIH/sidapublié 2021West African journal of medicinePubMeddocument de 3 observations

6,3 %Major PI resistance-associated mutation V82L was identified in 6.3% of CRF02_AG HIV-1 isolates.

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 11 observations

22,3 %Psychosocial variables contributed to variations in HIV-related stigma in Ottawa (22.3%), Miami (36.3%), and Port Harcourt (14.1%).

NigeriaVIH/sidapublié 2020Journal of racial and ethnic health disparitiesPubMeddocument de 5 observations

The majority of young people living with HIV are in sub-Saharan Africa.

NigeriaVIH/sidapublié 2021The patientPubMeddocument de 6 observations

35,8 %HIV testing and counseling (HTC) uptake among university students in Kano, Nigeria was 35.8%.

NigeriaVIH/sidapublié 2020International journal of STD & AIDSPubMeddocument de 2 observations

13,5 %Only 13.5% of the participants expressed the correct perceptions of the complementary relationship between HIV and TB.

Nigeriatuberculose · VIH/sidapublié 2024BMC public healthPubMeddocument de 4 observations

117 participantsThe study included 117 youth living with HIV/AIDS in Lagos State, Nigeria, with a mean age of 18.6 ± 2.6 years.

NigeriaVIH/sidaobservé 2022publié 2025African journal of reproductive healthPubMeddocument de 7 observations

20,8 %The case fatality rate among HIV-positive mpox cases was 20.8% (5/24).

Nigeriampox · VIH/sidaobservé 2017-2019publié 2023BMJ global healthPubMeddocument de 11 observations

50 %Women and girls account for more than 50% of the global HIV population.

NigeriaVIH/sidapublié 2024International journal of environmental research and public healthPubMeddocument de 2 observations

14,2 %Only 14.2% of children and young adolescents aged 0–14 years in Akwa-Ibom, Nigeria have been tested for HIV, according to the 2017 Akwa-Ibom AIDS Indicator Survey.

NigeriaVIH/sidaobservé 2017publié 2021BMC pediatricsPubMed

4 190 patientsIn the post-MMD6 group, 4,190 patients were included.

NigeriaVIH/sidapublié 2023African journal of AIDS research : AJARPubMeddocument de 5 observations

200 cells/mm³Higher MTCT rates were associated with CD4 counts below 200 cells/mm.

NigeriaVIH/sidapublié 2026International journal of STD & AIDSPubMeddocument de 2 observations

6,7 %HIV positivity rate at the TB clinic was 6.7% (95% CI: 0.9–35.2%).

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 16 observations

11,7 %Recent facility-based HIV testing uptake was higher among adolescents and young adults (AYA) with one sexual partner in the past 3 months by an unadjusted risk difference of 11.7%, compared to AYA with no recent sexual partners.

NigeriaVIH/sidapublié 2026AIDS (London, England)PubMeddocument de 7 observations

33 monthsThe non-parametric median survival time of TB patients co-infected with HIV was 33 months.

Nigeriatuberculose · VIH/sidapublié 2020PloS onePubMeddocument de 4 observations

75,9 %The frequency of cognitive impairment among CART-exposed patients was 75.9% (41 out of 54 patients).

NigeriaVIH/sidapublié 2026Annals of African medicinePubMeddocument de 7 observations